<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-pharmaceuticals-13-00313">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ryu</surname>
    <given-names>Y.B.</given-names>
   </name>
   <name>
    <surname>Jeong</surname>
    <given-names>H.J.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>Y.M.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>J.Y.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Naguyen</surname>
    <given-names>T.T.H.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>S.-J.</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Rho</surname>
    <given-names>M.-C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Biflavonoids from 
   <italic>Torreya nucifera</italic> displaying SARS-CoV 3CL (pro) inhibition
  </article-title>
  <source>Bioorg. Med. Chem.</source>
  <year>2010</year>
  <volume>18</volume>
  <fpage>7940</fpage>
  <lpage>7947</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bmc.2010.09.035</pub-id>
  <pub-id pub-id-type="pmid">20934345</pub-id>
 </element-citation>
</ref>
